Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today ...

Patients with FND live with genuine and debilitating symptoms; many of whom have been ignored, invalidated and left to ...

In a major step toward treating rare neurological diseases, scientists have used gene editing to correct mutations inside the ...

Ms Stocks says despite staying away from performing after her diagnosis, she continues to write music while at home. "When ...

LONDON, GREATER LONDON, UNITED KINGDOM, September 11, 2025 /EINPresswire.com/ -- What Is The Expected Cagr For The Gene Therapy On Neurological Diseases Market Through 2025? Rapid expansion has been ...